135 related articles for article (PubMed ID: 25439039)
1. Open-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancer.
Freyer G; You B; Villet S; Tartas S; Fournel-Federico C; Trillet-Lenoir V; Hamizi S; Colomban O; Chavernoz N; Falandry C
Homeopathy; 2014 Oct; 103(4):232-8. PubMed ID: 25439039
[TBL] [Abstract][Full Text] [Related]
2. Treatment with Ruta graveolens 5CH and Rhus toxicodendron 9CH may reduce joint pain and stiffness linked to aromatase inhibitors in women with early breast cancer: results of a pilot observational study.
Karp JC; Sanchez C; Guilbert P; Mina W; Demonceaux A; Curé H
Homeopathy; 2016 Nov; 105(4):299-308. PubMed ID: 27914569
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumour activity of Ruta graveolens extract.
Preethi KC; Kuttan G; Kuttan R
Asian Pac J Cancer Prev; 2006; 7(3):439-43. PubMed ID: 17059340
[TBL] [Abstract][Full Text] [Related]
4. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
5. Anti-proliferative effects of homeopathic medicines on human kidney, colon and breast cancer cells.
Arora S; Aggarwal A; Singla P; Jyoti S; Tandon S
Homeopathy; 2013 Oct; 102(4):274-82. PubMed ID: 24050774
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle analysis and cytotoxic potential of Ruta graveolens against human tumor cell lines.
Varamini P; Soltani M; Ghaderi A
Neoplasma; 2009; 56(6):490-3. PubMed ID: 19728756
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of biologically active furanocoumarins in agitated cultures of Ruta graveolens L. and Ruta graveolens ssp. divaricata (Tenore) Gams.
Ekiert H; Czygan FC
Pharmazie; 2005 Aug; 60(8):623-6. PubMed ID: 16124408
[TBL] [Abstract][Full Text] [Related]
8. Ruta Graveolens intoxication.
Seak CJ; Lin CC
Clin Toxicol (Phila); 2007; 45(2):173-5. PubMed ID: 17364636
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.
Mu XL; Li LY; Zhang XT; Wang SL; Wang MZ
BMC Cancer; 2004 Aug; 4():51. PubMed ID: 15318946
[TBL] [Abstract][Full Text] [Related]
10. Effect of Ruta graveolens L. and Euphorbia peplus L. anti-inflammatory extracts on nutritional status of rats and the safety of their use.
Al-Okbi SY; El-Sayed EM; Ammar NM; El-Sayed NK; Abou-El Kassem LT
Indian J Exp Biol; 2002 Jan; 40(1):45-8. PubMed ID: 12561967
[TBL] [Abstract][Full Text] [Related]
11. Changes in quality of life during palliative chemotherapy for solid cancer.
Bang SM; Park SH; Kang HG; Jue JI; Cho IH; Yun YH; Cho EK; Shin DB; Lee JH
Support Care Cancer; 2005 Jul; 13(7):515-21. PubMed ID: 15678347
[TBL] [Abstract][Full Text] [Related]
12. Effect of homeopathic medicines on transplanted tumors in mice.
Es S; Kuttan G; Kc P; Kuttan R
Asian Pac J Cancer Prev; 2007; 8(3):390-4. PubMed ID: 18159975
[TBL] [Abstract][Full Text] [Related]
13. Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study.
Creutzfeldt A; Suling A; Oechsle K; Mehnert A; Atanackovic D; Kripp M; Arnold D; Stein A; Quidde J
BMC Palliat Care; 2016 Mar; 15():25. PubMed ID: 26928745
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic management of peritoneal ascitic sarcomatosis by Ruta graveolens: A study in experimental mice.
Law S; Sanyal S; Chatterjee R; Law A; Law A; Chattopadhyay S
Pathol Res Pract; 2018 Sep; 214(9):1282-1290. PubMed ID: 30025594
[TBL] [Abstract][Full Text] [Related]
15. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
[TBL] [Abstract][Full Text] [Related]
16. Methanolic extract of Ruta graveolens L. inhibits inflammation and oxidative stress in adjuvant induced model of arthritis in rats.
Ratheesh M; Shyni GL; Helen A
Inflammopharmacology; 2009 Apr; 17(2):100-5. PubMed ID: 19205849
[TBL] [Abstract][Full Text] [Related]
17. Dynamized ultra-low dilution of
Fuselier C; Dufay E; Berquand A; Terryn C; Bonnomet A; Molinari M; Martiny L; Schneider C
Cell Adh Migr; 2023 Dec; 17(1):1-13. PubMed ID: 36503402
[TBL] [Abstract][Full Text] [Related]
18. Clastogenic potential of Ruta graveolens extract and a homeopathic preparation in mouse bone marrow cells.
Preethi KC; Nair CK; Kuttan R
Asian Pac J Cancer Prev; 2008; 9(4):763-9. PubMed ID: 19256773
[TBL] [Abstract][Full Text] [Related]
19. Ruta graveolens L. induces death of glioblastoma cells and neural progenitors, but not of neurons, via ERK 1/2 and AKT activation.
Gentile MT; Ciniglia C; Reccia MG; Volpicelli F; Gatti M; Thellung S; Florio T; Melone MA; Colucci-D'Amato L
PLoS One; 2015; 10(3):e0118864. PubMed ID: 25785932
[TBL] [Abstract][Full Text] [Related]
20. Lack of antibacterial activity of Ruta graveolens extracts against Enterococcus fecalis.
Saeidinia A; Keihanian F; Delavar SF; Keihanian F; Ranjbar A; Karkan MF
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1371-4. PubMed ID: 27592474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
